IRIS
GUOLO, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.093
AS - Asia 782
NA - Nord America 389
SA - Sud America 95
AF - Africa 12
OC - Oceania 4
Totale 7.375
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.920
US - Stati Uniti d'America 355
SG - Singapore 307
CN - Cina 216
VN - Vietnam 170
BR - Brasile 63
FR - Francia 55
FI - Finlandia 40
HK - Hong Kong 24
DE - Germania 16
AR - Argentina 15
GB - Regno Unito 15
MX - Messico 14
CA - Canada 13
IQ - Iraq 9
BD - Bangladesh 8
CH - Svizzera 6
ID - Indonesia 6
IN - India 6
JP - Giappone 6
NL - Olanda 6
TR - Turchia 6
CO - Colombia 5
AU - Australia 4
KR - Corea 4
RU - Federazione Russa 4
BE - Belgio 3
EC - Ecuador 3
GR - Grecia 3
PH - Filippine 3
PK - Pakistan 3
PL - Polonia 3
SE - Svezia 3
TH - Thailandia 3
UA - Ucraina 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
PY - Paraguay 2
SI - Slovenia 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 7.375
Salva come PNG Salva come JPEG
Città #
Genoa 2.761
Genova 1.962
Rapallo 553
Vado Ligure 493
Singapore 136
San Jose 115
Ashburn 70
Ho Chi Minh City 58
Beijing 47
Lauterbourg 44
Hanoi 41
Helsinki 37
Council Bluffs 33
Hong Kong 24
New York 17
Rome 17
Santa Clara 15
Frankfurt am Main 14
Bordighera 12
Turin 11
Milan 10
Mexico City 9
Da Nang 8
Ancona 7
Los Angeles 7
Amsterdam 6
Hải Dương 6
Orem 6
Schiavon 6
São Paulo 6
Toronto 6
Zurich 6
Cardiff 5
Haiphong 5
Istanbul 5
La Spezia 5
Montreal 5
Paris 5
Baghdad 4
Brooklyn 4
London 4
Marseille 4
Phủ Lý 4
Sydney 4
Tianjin 4
Tokyo 4
Biên Hòa 3
Buffalo 3
Chicago 3
Djursholm 3
Lappeenranta 3
Naples 3
Perugia 3
Vĩnh Long 3
Warsaw 3
Athens 2
Bologna 2
Bắc Ninh 2
Can Tho 2
Catania 2
Curitiba 2
Dallas 2
Denver 2
Dois Vizinhos 2
Guangzhou 2
Hat Yai 2
Ljubljana 2
Madrid 2
Menfi 2
Ninh Bình 2
Parma 2
Phoenix 2
Quảng Ngãi 2
Rio de Janeiro 2
Savigliano 2
São Bernardo do Campo 2
Trieste 2
Valsamoggia 2
Điện Bàn 2
Abidjan 1
Abu Dhabi 1
Acalanes Ridge 1
Addis Ababa 1
Alajuela 1
Alcobaça 1
Algiers 1
Alvorada d'Oeste 1
Amarah 1
Americana 1
Amman 1
Ankara 1
Antananarivo 1
Antwerp 1
Anápolis 1
Apucarana 1
Aracaju 1
Araruama 1
Arima 1
As Sālimīyah 1
Ascurra 1
Totale 6.701
Salva come PNG Salva come JPEG
Nome #
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents 240
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide 230
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia 218
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 211
A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis 208
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas 203
Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives 195
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes 194
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma 192
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia 189
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 179
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question". 170
Harnessing NK Cells for Cancer Treatment 170
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 170
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 168
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs 166
Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients 166
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach 164
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 163
Chronic graft versus host disease as a weapon for treating chronic myelomonocytic leukemia 162
Adoptive Cell Therapy and Immune Check Points Inhibitors As a Salvage Treatment for Patient Affected By Relapsed/Refractory Hodgkin's Lymphoma 158
Amino acid depletion triggered by L-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death 146
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas 146
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 144
Fludarabine, high-dose cytarabine and idarubicin-based induction may overcome the negative prognostic impact of flt3-itd in npm1 mutated aml, irrespectively of flt3-itd allelic Burden 140
Nucleophosmin gene-based monitoring in de novo cytogenetically normal acute myeloid leukemia with nucleophosmin gene mutations: comparison with cytofluorimetric analysis and study of Wilms tumor gene 1 expression. 132
POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA PATIENTS: A SAFE AND EFFECTIVE THERAPY ASSOCIATED WITH EXPANSION AND MATURATION OF NK CELLS 130
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 129
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment 129
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia. 128
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program 127
NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA 121
Harnessing Immune Response in Acute Myeloid Leukemia 120
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia 118
A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML 111
Irradiazione Totale Linfonodalea intensità modulata con Tomoterapia Elicoidale in associazione a Melphalan come trattamento ablativo seguito da trapianto autologo di cellule staminali nei linfomi: effetti acuti e tardivi da uno studio pilota. 111
Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia. 107
CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma 98
Full Donor Chimerism After Allogeneic Hematopoietic Stem Cells Transplant For Myelofibrosis: The Role Of The Conditioning Regimen 96
Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis 87
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation 87
Polypharmacy and potentially inappropriate medications in patients requiring palliative care in hospitals and nursing homes: Evidence from a Ligurian point-prevalence multicenter study 84
Good tolerability of high dose colistin-based therapy in patients with haematological malignancies 81
Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS 79
Comparing Outcomes Between CPX-351 and Fludarabine-Based Induction in Secondary Acute Myeloid Leukemia in the Real-World Setting: The Prognostic Role of Measurable Residual Disease 79
Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients 78
Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire 76
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma 70
Rapidly ascending necrotizing myelopathy with widespread brain white matter involvement following intrathecal methotrexate and cytosine arabinoside treatment in an adult with T cell acute lymphoblastic leukemia 65
Management of early stage chronic myeloid leukemia: State-of-the-art approach and future perspectives 63
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 61
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 59
Safety and efficacy of 90Yttrium-Ibritumomab-Tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study 58
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice 56
Blastic plasmocitoid dendritic cell neoplasm with leukemic spread: a GIMEMA survey 49
Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment? 42
Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group 41
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study 41
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group 32
The protective role of HCWs communication for the distress of newly diagnosed people with leukemia and lymphoma 31
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic leukemia–like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study 24
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study 19
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience 16
Editorial: Precision medicine for acute myeloid leukemia 12
Totale 7.539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.663
article - articoli 23.931
book - libri 0
conference - conferenze 360
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.954
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021137 0 0 0 0 0 0 0 0 0 59 25 53
2021/2022422 11 14 31 52 22 35 19 86 29 44 24 55
2022/2023672 50 58 13 60 124 86 1 38 88 36 98 20
2023/2024591 19 39 19 75 45 124 46 117 13 15 35 44
2024/20251.594 42 95 45 104 124 165 162 308 48 83 202 216
2025/20262.616 363 150 287 304 348 177 345 115 235 292 0 0
Totale 7.539